Cornelia Anne Mundt

This inventor holds 21 USPTO granted patents and 9 published patent applications, plus 1 CIPO patent and 3 EPO patents, primarily in Monoclonal Antibodies. Top assignees: Agenus Inc., Ludwig Institute for Cancer Research Limited, Memorial Sloan Kettering Cancer Center. Active years: 2018-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Cornelia Anne Mundt. Retrieved from https://idiyas.com/inventor/cornelia-anne-mundt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 21 (Patent Applications = 9)

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 6)

EPO Patents = 3 (Patent Applications = 8)

Average Co-Inventor Count = 8.2

ph-index = 4

Forward Citations = 31(Granted Patents)

Location History:

Lorrach, DE (2018 - 2024)
Lörrach, DE (2019 - 2024)

Company Filing History:

Ludwig Institute for Cancer Research Limited

patents

11 out of 621

Memorial Sloan Kettering Cancer Center

patents

4. 2 out of 139

Ligand Pharmaceuticals, Inc.

patents

5. 1 out of 4

Mink Therapeutics, Inc.

where one patent can have more than one assignee

Years Active: 2018-2025

Loading Chart...

Areas of Expertise:

Anti-CTLA-4

Anti-PD-1

Anti-CD137

Anti-LAG-3

Anti-CD48

Antibody Drug Conjugates

T Cell Receptors

NY-ESO-1

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12492393 - ANTI-CD137 ANTIBODIES AND METHODS OF USE THEREOF (2025-12-09),

2. 12492257 - ANTI-CTLA-4 ANTIBODIES AND METHODS OF USE THEREOF (2025-12-09),

3. 12246066 - Anti-CTLA-4 antibodies and methods of use thereof (2025-03-11),

4. 12187795 - Anti-LAG-3 antibodies and methods of use thereof (2025-01-07),

5. 11999786 - Anti-CD48 antibodies, antibody drug conjugates, and uses thereof (2024-06-04),

6. 11993653 - Antibodies and methods of use thereof (2024-05-28),

7. 11993651 - Anti-lag-3 antibodies and methods of use thereof (2024-05-28),

8. 11638755 - Anti-CTLA-4 antibodies and methods of use thereof (2023-05-02),

9. 11613764 - T cell receptors that bind to NY-ESO-1 and methods of use thereof (2023-03-28),

10. 11345755 - Anti-PD-1 antibodies and methods of use thereof (2022-05-31),

11. 11267889 - Anti-CTLA-4 antibodies and methods of use thereof (2022-03-08),

12. 11242385 - Anti-CD137 antibodies and methods of use thereof (2022-02-08),

13. 11098117 - Anti-CD137 antibodies and methods of use thereof (2021-08-24),

14. 11013802 - Anti-CTLA-4 antibodies and methods of use thereof (2021-05-25),

15. 10912831 - Anti-CTLA-4 antibodies and methods of use thereof (2021-02-09),

Title: Cornelia Anne Mundt - Innovative Inventor from Lörrach

Introduction: Cornelia Anne Mundt is a pioneering inventor hailing from Lörrach, Germany. With a passion for innovation and a keen eye for detail, she has made significant contributions to the field of technology.

Latest Patents: Cornelia Anne Mundt holds several patents in the areas of renewable energy, sustainable materials, and smart home technologies. Her most recent patents focus on enhancing energy efficiency in residential buildings through innovative design solutions.

Career Highlights: Throughout her career, Cornelia Anne Mundt has been recognized for her groundbreaking inventions that have reshaped the way we interact with technology. Her work has been instrumental in advancing sustainability practices and improving the quality of life for individuals around the world.

Collaborations: Cornelia Anne Mundt has collaborated with leading research institutions and technology companies to bring her inventions to life. Her partnerships have led to the development of cutting-edge products that have set new industry standards.

Conclusion: Cornelia Anne Mundt's dedication to innovation and her commitment to creating a more sustainable future make her a standout figure in the world of inventors. Her inventive spirit continues to inspire others to push the boundaries of what is possible in technology.

Profile summary based on public USPTO records.